This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
BRF (BRFS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
In the closing of the recent trading day, BRF (BRFS) stood at $3.60, denoting a -3.74% move from the preceding trading day.
Hershey's Cocoa Challenge: Will Demand Shaping Offset Costs?
by Zacks Equity Research
HSY leans on demand shaping and pricing strategy to ease elevated cocoa and tariff costs.
The J. M. Smucker Stock Nears 52-Week Low: Opportunity or Red Flag?
by Zacks Equity Research
SJM stock nears its 52-week low as weak pet food and snack sales, rising costs and tariffs pressure margins.
Gross Profit Under Pressure: Can Mondelez Withstand Cocoa Surge?
by Zacks Equity Research
MDLZ's pricing power and brand loyalty are tested as cocoa inflation dents margins despite solid first-quarter revenue growth.
AB InBev Strengthens U.S. Manufacturing Investment in Houston Brewery
by Zacks Equity Research
BUD invests $17 million in its Houston brewery as part of a $300 million U.S. upgrade, boosting jobs and long-term brewing innovation.
Conagra Down 12% in Three Months: Solid Bargain or Risky Bet
by Zacks Equity Research
CAG's nearly 12% slide in three months reflects inflation, weak volumes and foreign exchange hits-value play or value trap?
Campbell Stock Hits 52-Week Low: Temporary Dip or Deeper Concern?
by Zacks Equity Research
CPB stock nears a 52-week low as weak snack sales, cost inflation and a muted outlook weigh on investor sentiment.
UNFI's Q3 Earnings & Sales Beat Estimates on Wholesale Volume Growth
by Zacks Equity Research
United Natural posts third-quarter earnings and sales beat, driven by 4% wholesale volume growth and a 12% surge in natural product sales.
The J.M. Smucker Q4 Earnings Top Estimates, Sales Down 3% Y/Y
by Zacks Equity Research
SJM's fourth-quarter results show mixed performance amid divestitures and acquisitions, with fiscal 2026 outlook guiding soft EPS.
Casey's Q4 Earnings Top Estimates, Inside Same-Store Sales Rise 1.7%
by Zacks Equity Research
CASY's strong fourth-quarter performance is driven by robust inside sales, increased fuel gallons sold and continued operational efficiencies.
BRFS vs. CELH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
BRFS vs. CELH: Which Stock Is the Better Value Option?
Ollie's Bargain Q1 Earnings Top Estimates, Comps Up 2.6% Y/Y
by Zacks Equity Research
OLLI's value model pays off in the first quarter of 2025, with better-than-expected results and 25 new stores fueling top-line growth.
How to Play Constellation Brands Stock After a 27% Drop in 6 Months
by Zacks Equity Research
The STZ stock faces pressure from slowing beer sales and margin concerns, even as premium brands and expansion plans offer long-term hope.
Campbell's Q3 Earnings Top Estimates, Organic Sales Up on Volume Gains
by Zacks Equity Research
CPB beats Q3 sales and earnings estimates as Meals & Beverages drives organic growth, but Snacks' weakness weighs on the full-year outlook.
Hormel Foods Q2 Earnings Meet Estimates, Sales Increase Y/Y
by Zacks Equity Research
HRL meets second-quarter earnings estimates as sales rise 0.4% year over year and volumes decline, but International units post modest net sales gains.
BRFS or CELH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BRFS vs. CELH: Which Stock Is the Better Value Option?
Colgate Stock Slips 7% in a Month: What's the Best Move Now?
by Zacks Equity Research
With CL's stock declining and valuation stretched, is it time for caution, booking profits or rethinking your approach?
Wall Street Analysts See BRF (BRFS) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), BRF (BRFS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Post Holdings Q2 Earnings Beat Estimates, FY25 Outlook Raised
by Zacks Equity Research
POST's fiscal second-quarter results show a year-over-year sales decline, due to mixed segment trends. Management raises its 2025 outlook.
Central Garden & Pet Q2 Earnings Surpass Estimates, Rise Y/Y
by Zacks Equity Research
CENT's Q2 results reflect solid performance amid headwinds, with improved margins and EPS fueled by productivity gains despite a softer top-line performance.
BGS Q1 Earnings & Sales Miss Estimates Due to Weak Volumes & Pricing
by Zacks Equity Research
B&G Foods'` fiscal first-quarter results reflect weak volumes and pricing, with a 10.5% sales drop. Management revises its 2025 outlook.
COTY's Q3 Earnings Miss Due to Market Challenges and FX Headwinds
by Zacks Equity Research
Coty posts weak third-quarter fiscal 2025 results hit by foreign exchange headwinds and market uncertainty.
Grocery Outlet Q1 Earnings Surpass Estimates, Margin Expands
by Zacks Equity Research
GO's Q1 results reflect comparable store sales growth, higher store traffic and notable margin improvements, fueling strong overall revenue performance.
Clorox Q3 Earnings & Sales Miss Estimates, Margin Expands, Stock Down
by Zacks Equity Research
CLX's Q3 results show strong core fundamentals, market share stability, and gross margin expansion despite economic headwinds and shifting shopping habits.
THS Q1 Earnings Beat Estimates, Sales Decline on Lower Volumes
by Zacks Equity Research
TreeHouse Foods' Q1 results reflect higher earnings. However, sales decline due to unfavorable volume/mix amid ongoing macroeconomic consumption challenges.